Your browser doesn't support javascript.
loading
How Long-Term Care Quality Measures Address Alzheimer's Disease and Related Dementias in European Countries.
Lepore, Michael; Zúñiga, Franziska; Schols, Jos M G A; Wingenfeld, Klaus; van Achterberg, Theo; Murray, Briana.
Afiliação
  • Lepore M; University of Maryland School of Nursing, Baltimore, MD, USA. Electronic address: mlepore@umaryland.edu.
  • Zúñiga F; University of Basel, Nursing Science, Basel, Switzerland.
  • Schols JMGA; Department of Health Services Research and Department of Family Medicine, CAPHRI-Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
  • Wingenfeld K; Institute of Nursing Science at the University of Bielefeld, Bielefeld, Germany.
  • van Achterberg T; KU Leuven, Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, Leuven, Belgium.
  • Murray B; University of Maryland School of Nursing, Baltimore, MD, USA.
J Am Med Dir Assoc ; 24(5): 729-734, 2023 05.
Article em En | MEDLINE | ID: mdl-36977501
ABSTRACT

OBJECTIVES:

Alzheimer's disease and related dementias (ADRD) are prevalent conditions in long-term care homes (LTCHs) with most LTCH residents living with ADRD in many countries. Despite the prevalence of ADRD in LTCHs, a recent examination of LTCH quality measurement programs in 4 countries revealed few LTCH quality measures addressed ADRD, most commonly as a risk adjuster. We sought to better understand how quality measurement programs address ADRD internationally.

DESIGN:

International comparative analysis. SETTING AND

PARTICIPANTS:

We examined LTCH quality measures in 4 European countries-Germany, Switzerland, Belgium, and the Netherlands.

METHODS:

The specifications to calculate each measure were assessed to determine whether the measure was calculated without assessing for ADRD, included only residents with ADRD, excluded residents with ADRD, or was risk adjusted for the presence of ADRD among the LTCH residents.

RESULTS:

A total of 143 measures were examined across 4 quality measurement programs. Thirty-seven percent of the measures explicitly address ADRD. The programs addressed ADRD in starkly different ways. In Germany, most (13 of 15) measures addressed ADRD, and did so as an exclusion or inclusion criterion, and in Switzerland all the measures addressed ADRD through risk adjustment. In Flanders, Belgium, all measures were calculated without assessing for ADRD. In the Netherlands, one-third of the measures explicitly addressed ADRD by restricting the measure to psychogeriatric units. CONCLUSIONS AND IMPLICATIONS Although limited to examining measures from LTCH quality measurement programs in 4 European countries, this study adds evidence that ADRD tends not to be addressed by LTCH quality measures, but when ADRD is addressed, it tends to be through inclusion or exclusion criteria. LTCH regulators, policymakers, and providers can use this information to assess options for addressing ADRD in quality measurement programs. Future research is needed to assess how standard indicators of ADRD care quality differ across quality measurement programs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article